Each of the Morgan Stanley closed-end funds listed below (the “Funds”) today declared the following dividends. RECORD DATE PAYABLE DATE 9/30/24 10/15/ ...

Let’s take the day as an opportunity to reflect on, and express gratitude for, the good things and amazing people we have ...

The utility company is seeking about 100 graduates to join its award-winning graduate programme in September 2025, spanning ...

The approval for the KEYTRUDA regimen is supported by results from the Phase II/III IND.227/KEYNOTE-483 trial.

Beauty Yaurient is a professional makeup brushes manufacturer at Shenzhen ... Asia and others more than 100 countries and regions.We can provide all our raw materials' MSDS and our finish goods were ...

Physical fatigue is considered to be a "progressive inability to perform a task" due to a reduction in strength, speed or movement capacities. Such fatigue can impair motor function, and therefore the ...

A Kentucky state lawmaker has taken to social media to call out what he believes are excessive salaries and pay raises for ...

Researchers compared health-related quality of life with nivolumab added to first-line chemo vs chemo alone in patients with ...

LOUISVILLE, Ky. (WAVE) - Louisville’s Metropolitan Sewer District is under scrutiny over recent salary increases. MSD’s CEO ...

Scorpio Gold Corporation (TSXV: SGN) (OTCQB: SRCRF) (FSE: RY9) (“Scorpio Gold”, “Scorpio”, or the “Company”) is pleased to announce that it will be participating in the upcoming Metals Investor Forum ...

In 2021, the FDA criticised MSD for relying on an early endpoint to seek approval for Keytruda in early-stage TNBC.

The NIAGARA trial with Imfinzi is the first study to show an OS benefit in both the neoadjuvant and adjuvant settings.